Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
POLICY PAPERS
April 15, 2024
WORKING PAPERS
April 15, 2024
CGD NOTES
April 11, 2024
WORKING PAPERS
April 11, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
WORKING PAPERS
March 21, 2024
Since 2011, the World Bank’s education strategy has emphasized the need to shift focus from schooling to learning, and towards primary education with special attention to foundational skills. But this shift is not always easy to see in the actual lending data. Coding new details on 25 years of World...
WORKING PAPERS
February 22, 2024
Antibiotic resistance (ABR) already contributes to almost five million deaths per year. Without action, this number will likely rise substantially. We provide the first comprehensive assessment of the economic drivers of ABR, arguing that ABR in large part arises from extensive unresolved market (an...
WORKING PAPERS
April 25, 2023
This paper examines the link between ministerial continuity in borrower governments and the performance of World Bank education projects implemented between 2000 and 2017 in 114 countries. I use a combination of quantitative and qualitative methods to trace the link between number of ministers durin...
WORKING PAPERS
January 28, 2022
Providing patients with high-quality essential medicines requires a well-functioning procurement, distribution, and regulatory system. However, in many low- and lower-middle-income countries (LMICs), public sector supply chain performance is far from optimal, resulting in frequent stockouts at healt...
WORKING PAPERS
June 29, 2021
COVID-19 has caused significant morbidity and mortality, both directly and indirectly via the disruption to routine health services. Evidence on the indirect health impacts has largely been anecdotal or modeled, and cause/program-specific. We aimed to document the indirect health impacts in four cou...
WORKING PAPERS
December 14, 2020
Between 2011 and 2016, the Affordable Medicines Facility-Malaria (AMFm) subsidy program substantially increased access to WHO prequalified artemisinin combination therapies (ACTs) through Africa’s private sector pharmacies and drug-sellers. While the program was rigorously and extensively evaluated,...